As costs soar, shortages drag on and one-size-fits-all drugs leave patients behind, compounding pharmacies are emerging a corrective to a system engineered for scale but not nuance, efficiency but not empathy
Genetics, diet, exercise, starting weight, metabolic health, and adherence all influence individual outcomes
Beyond weight loss, semaglutide contributes to improvements in several health markers, reducing risks associated with heart disease, stroke, and type 2 diabetes
However, the FDA has not approved retatrutide for any indication
doi: Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al
While many folks do well with compounded versions, they are not FDA approved and may vary in consistency